TSHA - Taysha Gene Therapies, Inc.

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Revenue Growth YoY (%)	N/M	171.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2041%)	N/M	78.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+882%)	-32.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-506%)	-43.9% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-649%)	-62.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-879%)	-53.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-770%)	-27.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-444%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-50.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.0% Fair → Fair Stable Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	20.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	89.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	76.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-45.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	54.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	25.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	22.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-97.0% Weak ↓ Weak Declining Year-over-year change in net income	-48.3% Weak ↓ Weak Declining Year-over-year change in net income	-28.2% Weak ↓ Weak Declining Year-over-year change in net income	-28.4% Weak ↓ Weak Declining Year-over-year change in net income	10.5% Fair ↓ Fair Declining Year-over-year change in net income	N/M	78.2% Excellent ↑ Excellent Improving Year-over-year change in net income	14.9% Fair ↑ Fair Improving Year-over-year change in net income	-36.5% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-345.1% Weak ↓ Weak Declining Year-over-year change in net income	27.4% Excellent ↓ Excellent Declining Year-over-year change in net income	64.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-9.3% Weak ↓ Weak Declining Year-over-year change in net income	48.6% Excellent ↑ Excellent Improving Year-over-year change in net income	17.2% Good ↑ Good Improving Year-over-year change in net income	-56.5% Weak ↑ Weak Improving Year-over-year change in net income	-175.1% Weak ↑ Weak Improving Year-over-year change in net income	-240.3% Weak ↑ Weak Improving Year-over-year change in net income	-92.9% Weak ↑ Weak Improving Year-over-year change in net income	-489.7% Weak Weak Year-over-year change in net income	—	-48422.6% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	-36.4% Weak Weak Year-over-year change in free cash flow	—	—	—	5.2% Fair Fair Year-over-year change in free cash flow	—	—	—	77.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	-450.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3105%)	-342.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2383%)	—	-351.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2446%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-374.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3220%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-491.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-447.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-0.34x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.37x Good Good Free cash flow relative to reported net income Optimal: > 1x	-0.23x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Return on Invested Capital (%)	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	121.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1489.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-109.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.8% Good Good Return earned on debt + equity capital invested Optimal: > 10%	79.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-14.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-13.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-20.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-11.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-175%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-10.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-39.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-361%)	-26.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-275%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-44.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-398%)	63.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+325%)	238.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1489%)	66.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+342%)	117.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+686%)	—	-236.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1676%)	-103.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-790%)	-98.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-759%)	-52.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-452%)	-36.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-21.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	-14.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-7.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	79.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+428%)	97.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+550%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Debt to Equity (x)	0.23x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-61%)	0.20x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-66%)	0.23x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-61%)	0.17x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-72%)	0.77x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+29%)	0.61x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.48x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	0.35x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	0.75x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+25%)	0.54x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-10%)	-0.78x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-231%)	-1.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-272%)	-2.55x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-525%)	40.01x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+6568%)	3.40x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+466%)	1.15x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+91%)	0.74x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+23%)	0.39x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-30.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-788.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-838.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12.62x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-11.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-41.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-58.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-71.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-93.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	-210.16x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-15041.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-206.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-227.62M	$-269.66M	$-246.49M	$-271.71M	$-74.14M	$-95.09M	$-114.72M	$-134.91M	$-83.47M	$-103.43M	$-125.73M	$-6.73M	$-25.26M	$-49.91M	$3.47M	$-28.66M	$-59.24M	$-111.91M	$-160.97M	$-197.37M	$-228.68M	$-251.25M	$-278.63M	—	—	—	—
Debt / EBITDA (x)	-1.13x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.79x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.50x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.55x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.01x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.24x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.68x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.80x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.69x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.55x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.42x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.67x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.35x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.71x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.52x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.15x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.76x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.75x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.01	$0.01	—	$0.01	$0.00	$0.01	—	$0.04	$0.04	$0.07	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.12	$-0.08	$-0.09	$-0.09	$-0.08	$-0.07	$-0.10	$-0.09	$-0.10	$0.92	$-0.93	$-0.38	$-0.28	$-0.99	$-0.64	$-0.84	—	$-1.33	—	$-1.09	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.11	—	$-0.07	$-0.07	$-0.08	—	—	—	$-0.09	—	—	—	$-0.38	—	—	—	—	—	—	$-0.69	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.74	$0.87	$0.80	$0.91	$0.27	$0.35	$0.43	$0.54	$0.29	$0.40	$-0.26	$-0.58	$-0.24	$0.02	$0.27	$0.80	$1.32	$2.48	$3.65	$4.98	$5.90	$6.65	—	—	—	$0.00	—
Tangible Book Value per Share (USD)	$0.74	$0.87	$0.80	$0.91	$0.27	$0.35	$0.43	$0.54	$0.29	$0.40	$-0.26	$-0.58	$-0.24	$0.02	$0.27	$0.80	$1.32	$2.48	$3.65	$4.98	$5.90	$6.65	—	—	—	$0.00	—
Basic Weighted Avg Shares (shares)	366.63M	—	353.31M	297.99M	269.31M	—	267.82M	232.82M	231.25M	—	125.70M	64.24M	63.26M	—	40.94M	40.14M	—	—	—	37.48M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Working Capital (USD)	$262.15M	$298.10M	$271.32M	$290.92M	$98.15M	$115.90M	$132.22M	$144.29M	$91.96M	$113.11M	$-8.64M	$3.47M	$17.90M	$33.63M	$9.86M	$33.88M	$58.27M	$107.86M	$153.96M	—	$220.67M	$250.75M	—	—	—	$-135.00K	—
LT Debt (USD)	$48.96M	$50.11M	$50.85M	$41.05M	$42.45M	$43.94M	$42.97M	$37.84M	$40.51M	$40.51M	$38.55M	$38.35M	$38.16M	$37.97M	$37.77M	$37.58M	$37.39M	$37.19M	$27.81M	—	—	—	—	—	—	—	—
Total Equity (USD)	$211.94M	$246.94M	$218.99M	$248.73M	$55.06M	$71.53M	$88.80M	$108.87M	$53.85M	$74.94M	$-49.11M	$-37.11M	$-14.95M	$949.00K	$11.13M	$32.71M	$50.73M	$95.38M	$140.39M	$186.50M	$222.87M	$251.30M	$267.64M	$-26.79M	$-5.57M	$0.00	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗
Sales/Revenue/Turnover (USD)	$0.00	$5.49M	$0.00	$1.99M	$2.30M	$2.02M	$1.79M	$1.11M	$3.41M	$3.60M	$4.75M	$2.40M	$4.71M	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$295.00K	$299.00K	$200.00K	$300.00K	$283.00K	$304.00K	$300.00K	$300.00K	$325.00K	$366.00K	$300.00K	$400.00K	$331.00K	$362.00K	$300.00K	$300.00K	$257.00K	$209.00K	$166.00K	$85.00K	$32.00K	$6.00K	$3.00K	$0.00	$0.00	—	$0.00
Net Income, GAAP (USD)	$-42.41M	$-27.85M	$-32.73M	$-26.88M	$-21.53M	$-18.79M	$-25.52M	$-20.93M	$-24.06M	$47.74M	$-117.09M	$-24.60M	$-17.62M	$-55.08M	$-26.31M	$-33.87M	$-50.11M	$-50.39M	$-51.19M	$-40.93M	$-32.02M	$-18.32M	$-15.04M	$-21.22M	$-5.43M	—	$-31.00K
Operating Cash Flow (USD)	$-40.88M	$-26.72M	$-24.17M	$-20.18M	$-22.02M	$-18.31M	—	—	$-19.80M	$-16.12M	—	—	$-20.18M	$14.71M	—	—	$-40.80M	$-40.26M	—	$-22.82M	$-22.04M	$-19.85M	$-6.72M	$-2.47M	$-1.70M	—	$0.00

Taysha Gene Therapies, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TSHA with peers